Want to join the conversation?
$HIMX 2Q15 PR: Diluted earnings per ADS attributable to Himax stockholders was $0.051 compared to $0.14 in 2Q14. GAAP earnings per diluted ADS decreased to $0.05 from $0.07 in 1Q15, beating guidance. As of June 30 2015, Himax had 171.2MM ADSs outstanding, unchanged from 1Q15. On a fully diluted basis, the total number of ADSs outstanding is 172.2MM
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.